寡氯苯是炭疽杆菌的有效抑制剂。
Oligochlorophens are potent inhibitors of Bacillus anthracis.
机构信息
Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706-1544, USA.
出版信息
Antimicrob Agents Chemother. 2010 Sep;54(9):3988-90. doi: 10.1128/AAC.00067-10. Epub 2010 Jun 21.
Abstract
Bacterial cytoskeletal proteins are an emerging set of targets for antibiotic development. This paper describes oligochlorophen analogs based on the monomer 4-chloro-2,6-dimethylphenol as antimicrobial agents against Bacillus anthracis. The most potent analogs have a MIC of 160 to 320 nM against B. anthracis and may target the cytoskeletal protein FtsZ. B. anthracis develops resistance to the oligochlorophens at a rate of 4.34 x 10(-10) per generation, which is approximately 10-fold lower than that of commercial antibiotics used to treat this human pathogen.
摘要
细菌细胞骨架蛋白是一组新兴的抗生素开发靶点。本文描述了基于单体 4-氯-2,6-二甲基苯酚的寡氯苯类似物，作为抗炭疽芽孢杆菌的抗菌剂。最有效的类似物对炭疽芽孢杆菌的 MIC 为 160 至 320 nM，可能针对细胞骨架蛋白 FtsZ。炭疽芽孢杆菌对寡氯苯的耐药性产生速度为每代 4.34 x 10(-10)，比用于治疗这种人类病原体的商业抗生素低约 10 倍。
相似文献
1
Oligochlorophens are potent inhibitors of Bacillus anthracis.寡氯苯是炭疽杆菌的有效抑制剂。
Antimicrob Agents Chemother. 2010 Sep;54(9):3988-90. doi: 10.1128/AAC.00067-10. Epub 2010 Jun 21.
2
Structure-activity relationships of Bacillus cereus and Bacillus anthracis dihydrofolate reductase: toward the identification of new potent drug leads.蜡样芽孢杆菌和炭疽芽孢杆菌二氢叶酸还原酶的构效关系：寻找新型有效药物先导物
Antimicrob Agents Chemother. 2006 Oct;50(10):3435-43. doi: 10.1128/AAC.00386-06.
3
New inhibitors of colony spreading in Bacillus subtilis and Bacillus anthracis.枯草芽孢杆菌和炭疽芽孢杆菌菌落扩散的新型抑制剂。
Bioorg Med Chem Lett. 2011 Sep 15;21(18):5583-8. doi: 10.1016/j.bmcl.2011.06.082. Epub 2011 Jun 25.
4
Antimicrobial susceptibility of Bacillus anthracis strains from Hungary.来自匈牙利的炭疽芽孢杆菌菌株的抗菌药敏性。
Acta Vet Hung. 2016 Jun;64(2):141-7. doi: 10.1556/004.2016.015.
5
Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare.炭疽芽孢杆菌（一种有潜力用于生物战的细菌病原体）分离株的抗生素敏感性
Clin Microbiol Infect. 2003 Sep;9(9):984-6. doi: 10.1046/j.1469-0691.2003.00775.x.
6
Inhibition of Bacillus anthracis and potential surrogate bacilli growth from spore inocula by nisin and other antimicrobial peptides.乳酸链球菌素和其他抗菌肽对炭疽芽孢杆菌及潜在替代芽孢杆菌孢子接种物生长的抑制作用
J Food Prot. 2006 Oct;69(10):2529-33. doi: 10.4315/0362-028x-69.10.2529.
7
[Methodic approaches to testing Bacillus anthracis susceptibility to antibacterials].[检测炭疽芽孢杆菌对抗菌药物敏感性的方法学探讨]
Antibiot Khimioter. 2009;54(3-4):6-10.
8
Identification of Specific and Nonspecific Inhibitors of Bacillus anthracis Type III Pantothenate Kinase (PanK).鉴定炭疽杆菌 III 型泛酸激酶（PanK）的特异性和非特异性抑制剂。
ChemMedChem. 2019 Jan 8;14(1):78-82. doi: 10.1002/cmdc.201800652. Epub 2018 Dec 3.
9
Ebselen and analogs as inhibitors of Bacillus anthracis thioredoxin reductase and bactericidal antibacterials targeting Bacillus species, Staphylococcus aureus and Mycobacterium tuberculosis.依布硒啉及其类似物作为炭疽芽孢杆菌硫氧还蛋白还原酶的抑制剂以及针对芽孢杆菌属、金黄色葡萄球菌和结核分枝杆菌的杀菌性抗菌剂。
Biochim Biophys Acta. 2016 Jun;1860(6):1265-71. doi: 10.1016/j.bbagen.2016.03.013. Epub 2016 Mar 10.
10
In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.新型抗叶酸剂对耐甲氧苄啶炭疽芽孢杆菌的体外疗效
Antimicrob Agents Chemother. 2007 Dec;51(12):4447-52. doi: 10.1128/AAC.00628-07. Epub 2007 Sep 17.
引用本文的文献
1
Alternative pre-approved and novel therapies for the treatment of anthrax.用于治疗炭疽的替代预批准和新型疗法。
BMC Infect Dis. 2016 Nov 3;16(1):621. doi: 10.1186/s12879-016-1951-y.
2
Inhibitors of bacterial tubulin target bacterial membranes .细菌微管蛋白抑制剂作用于细菌细胞膜。
Medchemcomm. 2013 Jan 1;4(1):112-119. doi: 10.1039/C2MD20127E. Epub 2012 Jul 18.
3
New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.疫苗、炭疽毒素抑制剂以及炭疽杆菌抗生素治疗的新进展。
Curr Med Chem. 2011;18(33):5083-94. doi: 10.2174/092986711797636036.
本文引用的文献
1
Fluctuation analysis CalculatOR: a web tool for the determination of mutation rate using Luria-Delbruck fluctuation analysis.波动分析计算器：一种使用卢里亚-德尔布吕克波动分析来确定突变率的网络工具。
Bioinformatics. 2009 Jun 15;25(12):1564-5. doi: 10.1093/bioinformatics/btp253. Epub 2009 Apr 15.
2
An inhibitor of FtsZ with potent and selective anti-staphylococcal activity.一种具有强效和选择性抗葡萄球菌活性的FtsZ抑制剂。
Science. 2008 Sep 19;321(5896):1673-5. doi: 10.1126/science.1159961.
3
Cell-division inhibitors: new insights for future antibiotics.细胞分裂抑制剂：未来抗生素的新见解。
Nat Rev Drug Discov. 2008 Apr;7(4):324-38. doi: 10.1038/nrd2510.
4
Cytoskeletal elements in bacteria.细菌中的细胞骨架成分。
Annu Rev Microbiol. 2007;61:589-618. doi: 10.1146/annurev.micro.61.080706.093236.
5
Mutations of Bacteria from Virus Sensitivity to Virus Resistance.细菌从对病毒敏感到对病毒抗性的突变。
Genetics. 1943 Nov;28(6):491-511. doi: 10.1093/genetics/28.6.491.
6
The bacterial cytoskeleton.细菌细胞骨架
Microbiol Mol Biol Rev. 2006 Sep;70(3):729-54. doi: 10.1128/MMBR.00017-06.
7
Dynamic filaments of the bacterial cytoskeleton.细菌细胞骨架的动态细丝。
Annu Rev Biochem. 2006;75:467-92. doi: 10.1146/annurev.biochem.75.103004.142452.
8
MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest.采用Etest法测定来自一系列临床和环境来源的炭疽芽孢杆菌、蜡样芽孢杆菌、苏云金芽孢杆菌和蕈状芽孢杆菌对选定抗生素的最低抑菌浓度。
J Clin Microbiol. 2004 Aug;42(8):3626-34. doi: 10.1128/JCM.42.8.3626-3634.2004.
9
Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality.靶向细胞分裂：FtsZ GTP酶的小分子抑制剂扰乱细胞分裂环组装并诱导细菌死亡。
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11821-6. doi: 10.1073/pnas.0404439101. Epub 2004 Aug 2.
10
Selection of Bacillus anthracis isolates resistant to antibiotics.对抗生素具有抗性的炭疽芽孢杆菌分离株的筛选。
J Antimicrob Chemother. 2004 Aug;54(2):424-8. doi: 10.1093/jac/dkh258. Epub 2004 Jun 17.
Zotero 插件